Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial

Catherine E. Mosher, Ekin Secinti, Ruohong Li, Adam T. Hirsh, Jonathan Bricker, Kathy Miller, Bryan Schneider, Anna Maria Storniolo, Lida Mina, Erin V. Newton, Victoria Champion, Shelley Johns

Research output: Contribution to journalArticle

  • 1 Citations

Abstract

Purpose: Breast cancer is the leading cause of cancer mortality in women worldwide. With medical advances, metastatic breast cancer (MBC) patients often live for years with many symptoms that interfere with activities. However, there is a paucity of efficacious interventions to address symptom-related suffering and functional interference. Thus, this study examined the feasibility and preliminary efficacy of telephone-based acceptance and commitment therapy (ACT) for symptom interference with functioning in MBC patients. Methods: Symptomatic MBC patients (N = 47) were randomly assigned to six telephone sessions of ACT or six telephone sessions of education/support. Patients completed measures of symptom interference and measures assessing the severity of pain, fatigue, sleep disturbance, depressive symptoms, and anxiety. Results: The eligibility screening rate (64%) and high retention (83% at 8 weeks post-baseline) demonstrated feasibility. When examining within-group change, ACT participants showed decreases in symptom interference (i.e., fatigue interference and sleep-related impairment; Cohen’s d range = − 0.23 to − 0.31) at 8 and 12 weeks post-baseline, whereas education/support participants showed minimal change in these outcomes (d range = − 0.03 to 0.07). Additionally, at 12 weeks post-baseline, ACT participants showed moderate decreases in fatigue and sleep disturbance (both ds = − 0.43), whereas education/support participants showed small decreases in these outcomes (ds = − 0.24 and − 0.18 for fatigue and sleep disturbance, respectively). Both the ACT and education/support groups showed reductions in depressive symptoms (ds = − 0.27 and − 0.28) at 12 weeks post-baseline. Group differences in all outcomes were not statistically significant. Conclusions: ACT shows feasibility and promise in improving fatigue and sleep-related outcomes in MBC patients and warrants further investigation.

LanguageEnglish (US)
Pages1-12
Number of pages12
JournalSupportive Care in Cancer
DOIs
StateAccepted/In press - Jan 12 2018

Fingerprint

Acceptance and Commitment Therapy
Fatigue
Breast Neoplasms
Sleep
Telephone
Education
Depression
Self-Help Groups
Feasibility Studies
Anxiety
Pain
Mortality

Keywords

  • Acceptance and commitment therapy
  • Fatigue
  • Metastatic breast cancer
  • Psychosocial interventions
  • Sleep
  • Symptom interference

ASJC Scopus subject areas

  • Oncology

Cite this

Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients : a pilot randomized trial. / Mosher, Catherine E.; Secinti, Ekin; Li, Ruohong; Hirsh, Adam T.; Bricker, Jonathan; Miller, Kathy; Schneider, Bryan; Storniolo, Anna Maria; Mina, Lida; Newton, Erin V.; Champion, Victoria; Johns, Shelley.

In: Supportive Care in Cancer, 12.01.2018, p. 1-12.

Research output: Contribution to journalArticle

@article{5b7512b897274793a37089c8930b3147,
title = "Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients: a pilot randomized trial",
abstract = "Purpose: Breast cancer is the leading cause of cancer mortality in women worldwide. With medical advances, metastatic breast cancer (MBC) patients often live for years with many symptoms that interfere with activities. However, there is a paucity of efficacious interventions to address symptom-related suffering and functional interference. Thus, this study examined the feasibility and preliminary efficacy of telephone-based acceptance and commitment therapy (ACT) for symptom interference with functioning in MBC patients. Methods: Symptomatic MBC patients (N = 47) were randomly assigned to six telephone sessions of ACT or six telephone sessions of education/support. Patients completed measures of symptom interference and measures assessing the severity of pain, fatigue, sleep disturbance, depressive symptoms, and anxiety. Results: The eligibility screening rate (64{\%}) and high retention (83{\%} at 8 weeks post-baseline) demonstrated feasibility. When examining within-group change, ACT participants showed decreases in symptom interference (i.e., fatigue interference and sleep-related impairment; Cohen’s d range = − 0.23 to − 0.31) at 8 and 12 weeks post-baseline, whereas education/support participants showed minimal change in these outcomes (d range = − 0.03 to 0.07). Additionally, at 12 weeks post-baseline, ACT participants showed moderate decreases in fatigue and sleep disturbance (both ds = − 0.43), whereas education/support participants showed small decreases in these outcomes (ds = − 0.24 and − 0.18 for fatigue and sleep disturbance, respectively). Both the ACT and education/support groups showed reductions in depressive symptoms (ds = − 0.27 and − 0.28) at 12 weeks post-baseline. Group differences in all outcomes were not statistically significant. Conclusions: ACT shows feasibility and promise in improving fatigue and sleep-related outcomes in MBC patients and warrants further investigation.",
keywords = "Acceptance and commitment therapy, Fatigue, Metastatic breast cancer, Psychosocial interventions, Sleep, Symptom interference",
author = "Mosher, {Catherine E.} and Ekin Secinti and Ruohong Li and Hirsh, {Adam T.} and Jonathan Bricker and Kathy Miller and Bryan Schneider and Storniolo, {Anna Maria} and Lida Mina and Newton, {Erin V.} and Victoria Champion and Shelley Johns",
year = "2018",
month = "1",
day = "12",
doi = "10.1007/s00520-018-4045-0",
language = "English (US)",
pages = "1--12",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients

T2 - Supportive Care in Cancer

AU - Mosher, Catherine E.

AU - Secinti, Ekin

AU - Li, Ruohong

AU - Hirsh, Adam T.

AU - Bricker, Jonathan

AU - Miller, Kathy

AU - Schneider, Bryan

AU - Storniolo, Anna Maria

AU - Mina, Lida

AU - Newton, Erin V.

AU - Champion, Victoria

AU - Johns, Shelley

PY - 2018/1/12

Y1 - 2018/1/12

N2 - Purpose: Breast cancer is the leading cause of cancer mortality in women worldwide. With medical advances, metastatic breast cancer (MBC) patients often live for years with many symptoms that interfere with activities. However, there is a paucity of efficacious interventions to address symptom-related suffering and functional interference. Thus, this study examined the feasibility and preliminary efficacy of telephone-based acceptance and commitment therapy (ACT) for symptom interference with functioning in MBC patients. Methods: Symptomatic MBC patients (N = 47) were randomly assigned to six telephone sessions of ACT or six telephone sessions of education/support. Patients completed measures of symptom interference and measures assessing the severity of pain, fatigue, sleep disturbance, depressive symptoms, and anxiety. Results: The eligibility screening rate (64%) and high retention (83% at 8 weeks post-baseline) demonstrated feasibility. When examining within-group change, ACT participants showed decreases in symptom interference (i.e., fatigue interference and sleep-related impairment; Cohen’s d range = − 0.23 to − 0.31) at 8 and 12 weeks post-baseline, whereas education/support participants showed minimal change in these outcomes (d range = − 0.03 to 0.07). Additionally, at 12 weeks post-baseline, ACT participants showed moderate decreases in fatigue and sleep disturbance (both ds = − 0.43), whereas education/support participants showed small decreases in these outcomes (ds = − 0.24 and − 0.18 for fatigue and sleep disturbance, respectively). Both the ACT and education/support groups showed reductions in depressive symptoms (ds = − 0.27 and − 0.28) at 12 weeks post-baseline. Group differences in all outcomes were not statistically significant. Conclusions: ACT shows feasibility and promise in improving fatigue and sleep-related outcomes in MBC patients and warrants further investigation.

AB - Purpose: Breast cancer is the leading cause of cancer mortality in women worldwide. With medical advances, metastatic breast cancer (MBC) patients often live for years with many symptoms that interfere with activities. However, there is a paucity of efficacious interventions to address symptom-related suffering and functional interference. Thus, this study examined the feasibility and preliminary efficacy of telephone-based acceptance and commitment therapy (ACT) for symptom interference with functioning in MBC patients. Methods: Symptomatic MBC patients (N = 47) were randomly assigned to six telephone sessions of ACT or six telephone sessions of education/support. Patients completed measures of symptom interference and measures assessing the severity of pain, fatigue, sleep disturbance, depressive symptoms, and anxiety. Results: The eligibility screening rate (64%) and high retention (83% at 8 weeks post-baseline) demonstrated feasibility. When examining within-group change, ACT participants showed decreases in symptom interference (i.e., fatigue interference and sleep-related impairment; Cohen’s d range = − 0.23 to − 0.31) at 8 and 12 weeks post-baseline, whereas education/support participants showed minimal change in these outcomes (d range = − 0.03 to 0.07). Additionally, at 12 weeks post-baseline, ACT participants showed moderate decreases in fatigue and sleep disturbance (both ds = − 0.43), whereas education/support participants showed small decreases in these outcomes (ds = − 0.24 and − 0.18 for fatigue and sleep disturbance, respectively). Both the ACT and education/support groups showed reductions in depressive symptoms (ds = − 0.27 and − 0.28) at 12 weeks post-baseline. Group differences in all outcomes were not statistically significant. Conclusions: ACT shows feasibility and promise in improving fatigue and sleep-related outcomes in MBC patients and warrants further investigation.

KW - Acceptance and commitment therapy

KW - Fatigue

KW - Metastatic breast cancer

KW - Psychosocial interventions

KW - Sleep

KW - Symptom interference

UR - http://www.scopus.com/inward/record.url?scp=85040366988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040366988&partnerID=8YFLogxK

U2 - 10.1007/s00520-018-4045-0

DO - 10.1007/s00520-018-4045-0

M3 - Article

SP - 1

EP - 12

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

ER -